TABLE 2.
RISK OF LUNG CANCER DEVELOPMENT BASED ON THE DOSE OF INHALED CORTICOSTEROIDS
Triamcinalone Equivalents | Person-Years at Risk | Total (n = 10,474) | Lung Cancer (n = 423) | Unadjusted HR (95% CI) | Adjusted HR* (95% CI) |
---|---|---|---|---|---|
Continuous | |||||
Per 100 μg/d | 33,436 | 10,474 | 423 | 0.98 (0.95–1.02) | 0.96 (0.93–1.00) |
Categorical | |||||
Nonusers | 31,799 | 9,957 | 402 | Referent | Referent |
< 1,200 (μg/d) | 928 | 298 | 16 | 1.36 (0.83–2.25) | 1.13 (0.67–1.90) |
⩾ 1,200 (μg/d) | 709 | 219 | 5 | 0.56 (0.23–1.36) | 0.39 (0.16–0.96) |
Definition of abbreviations: CI = confidence interval; HR = hazard ratio; ICS = inhaled corticosteroids.
Adjusted for age, smoking status and smoking intensity, history of malignancy other than skin cancer, Seattle Index of Comorbidity score, and bronchodilator use.